Advanced Biomed Inc. (ADVB) Return on Investment ROI from the fourth quarter of 2026 to fourth quarter of 2025 and for the year 2026, average high and low, overall ranking from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Advanced Biomed Inc.  (Nasdaq: ADVB)
    Sector • Healthcare    Industry • Medical Laboratories
   Industry • Medical Laboratories
   Sector • Healthcare


Advanced Biomed's ROI from its fourth quarter of 2026 to the fourth quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Advanced Biomed's ROI in the fourth quarter of 2026?
Advanced Biomed Inc. achieved a return on average invested assets (ROI) of 101.35 % in its fourth quarter of 2026, this is above ADVB's average return on investment of 89.46%.
Advanced Biomed Inc. invested over the 12 months ending in its fourth quarter of 2026 $7 million

ROI has improved compared to 81.85% in the third quarter of 2026, due to net income growth.

Within the Healthcare sector 10 other companies had a higher return on investment. While Return on investment, overall ranking has progressed in the Jun 30 2026 quarter, so far to 52, from total ROI ranking in the third quarter of 2026 at 68.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Jun 30 2026)
IV. Quarter		 (Mar 31 2026)
III. Quarter		 (Dec 31 2025)
II. Quarter		 (Sep 30 2025)
I. Quarter		 (Jun 30 2025)
IV. Quarter
Y / Y Investment Change TTM 45.25 % 302.45 % 808.11 % 1080.3 % -
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 12 9 2 3 12
Return On Investment (TTM) 101.35 % 81.85 % 84.64 % -68.87 % -71.85 %
ADVB's Overall Ranking # 52 # 68 # # #
Seq. Investment Change TTM 2.12 % 24.51 % 5.57 % 8.21 % 182.94 %
Seq. Net Income Change TTM 26.45 % 20.41 % - - -
Net Income (TTM) in Millions 7 5 4 -3 -3

ADVB Company Profile >> Back to ADVB Roi Comparisons >> See Annual ADVB Return On Investment



Return On Investment ADVB's Ranking
Within: No.
Industry # 2
Sector # 11
Overall # 52

Return On Investment Statistics
High Average Low
101.54 %
89.46 %
82.01 %
(Jun 30 2026)   (Mar 31 2026)







Financial Statements
Advanced Biomed's IV. Quarter Investments $ 12 Millions ADVB's Balance sheet
Advanced Biomed's IV. Quarter Income $ 1 Millions Quarterly ADVB's Income Statement
ADVB's Income by Division See ADVB's Income by Division


ADVB Annual Return On Investment (Jun 30 2026)
2026		 (Jun 30 2024)
2025


Total Investments in Millions 12 2 0 0 0
Y / Y Investment Growth 638.09 % - - - -
Net Income in Millions 7 -3 0 0 0
Y / Y Net Income Growth - - - - -
Annual Return On Investment 54.39 % -167.28 % - - -


Annual Roi Comment
In the fiscal year 2026 ROI improved to 54.39 % compared to the prior year, due to net income growth.

Definition and Formula of Return on Investment

Other ROI Ratios
Medical Laboratories Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
ADVB's Roi Ratio versus Medical Laboratories Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for ADVB's Competitors
Subscribers only: Roi for Advanced Biomed's Suppliers
Subscribers only: Return On Investment for ADVB's Customers

Other Ratios
ADVB's Roa ADVB's Inventory Turnover Ratio ADVB's Growth Rates ADVB's Dividend Statistics
ADVB's Profitability Ratios ADVB's Asset Turnover Ratio ADVB's Dividend Growth
ADVB's Roe ADVB's Valuation Ratios ADVB's Financial Strength Ratios ADVB's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2026, within Healthcare Sector ROI
Omeros Corporation  198.34 %
Elutia Inc   191.75 %
Vor Biopharma Inc   162.71 %
Capforce Inc   161.42 %
Kyntra Bio Inc   157.74 %
Silexion Therapeutics Corp  127.60 %
Quince Therapeutics Inc   112.49 %
Advanced Biomed Inc.  101.54 %
Interpace Biosciences Inc   100.71 %
Sanuwave Health Inc   91.81 %
Rigel Pharmaceuticals Inc  89.00 %
Oncotelic Therapeutics Inc   87.35 %
Arbutus Biopharma Corp  85.89 %
Actinium Pharmaceuticals Inc  84.38 %
Exelixis Inc   82.05 %
Lensar Inc   75.31 %
Ironwood Pharmaceuticals inc   70.54 %
Oramed Pharmaceuticals Inc  68.90 %
Indivior Pharmaceuticals Inc   68.79 %
Rallybio Corporation  68.28 %
Fortress Biotech Inc   68.27 %
Escalon Medical Corp   64.70 %
Earth Science Tech Inc   64.38 %
Meiragtx Holdings Plc  55.83 %
Elite Pharmaceuticals Inc   53.48 %
Idexx Laboratories Inc  51.80 %
Aurinia Pharmaceuticals Inc   50.35 %
Qhslab Inc   48.94 %
Q32 Bio Inc   47.43 %
Vaxart Inc   46.17 %

Date modified: 2026-10-14T16:54:44+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.